Back to search results

Screening for Sexual Dysfunction in Young Cancer Patients and Survivors

This study is developing and testing a new way to screen for sexual health issues (sexual dysfunction) in young people (ages 15-24) who have or have had childhood cancer. It uses a tool called the PROMIS SexFS Brief to help doctors and patients talk about these concerns. The goal is to make it easier to identify and address sexual health problems, which can improve the quality of life for these patients. The study aims to see if using this screening approach helps patients and doctors communicate better about sexual function. This is an interventional study, meaning it involves a specific action (the screening approach).

Study design
This interventional study plans to enroll 205 participants aged 15 to 24. It uses a pre-post design, comparing communication about sexual function before and after the screening approach is implemented.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, communication about sexual function, will be measured at 5 years after the intervention is implemented.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05524610

Development and Evaluation of a Screening Approach for Sexual Dysfunction in AYA Patients With and Surviving Childhood Cancer

Recruiting
NAAges 15–24InterventionalSupportive care
University of Colorado, Denver
~205 participants
Updated 2026-05-06 on ClinicalTrials.gov
What's tested:Sexual Function Screening Approach

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Comparison of sexual function communication before and after intervention implementation
Measured over 5 years

Conditions

Pediatric Cancer
Survivorship

Explore related trials

Childhood Malignant Neoplasm

Where it's being run

2 sites across 1 states
Colorado2

Study leadership

  • Jenna Demedis · PRINCIPAL_INVESTIGATOR · University of Colorado, Denver

Who to contact

Barbara Shepperd
[email protected]
7207776819
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Chemotherapy: any anticancer drug to treat the cancer diagnosis including immunotherapy
Radiotherapy: any radiotherapy to treat the cancer diagnosis
Surgery: any surgery to remove cancer including partial or total resections. Biopsies are not considered surgery. 6. Cancer must have been diagnosed before the age of 18 years 7. Patient must have an appointment at one of four clinical sites: CHCO HOPE Survivorship Program, CHCO Oncology Clinic, CHCO Neuro-Oncology Clinic, Seattle Children's Hospital Survivorship Program

What this trial measures

  • Comparison of sexual function communication before and after intervention implementation5 years

    Comparison of pre- and post- intervention percentage of patients reporting that his/her provider has communicated with them about sexual function Subjects will report (yes or no) via survey after their healthcare visit.